COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series-Reference-Cited by-同舟云学术

COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series

Published:2021-11 Issue: Volume:44 Page:102169
ISSN:1477-8939
Container-title:Travel Medicine and Infectious Disease
language:en
Short-container-title:Travel Medicine and Infectious Disease

Author:

Elzouki Abdel-Naser^ORCID,Osman Maab A.M.,Ahmed Mohanad A.E.,Al-Abdulmalek Abdulrahman^ORCID,Altermanini Mohammad,Al-Ani Haneen A.,Naeem Muhammad,Habas Elmukhtar^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference110 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

2. Pulmonary and extra-pulmonary clinical manifestations of COVID-19;Johnson;Front Med,2020

3. A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report;Aasfara;Pan Afr Med J,2021

4. A rare axonal variant of Guillain barré syndrome as a neurological complication of COVID-19 infection;Abbaslou;Arch Iran Med,2020

5. Guillain- Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: a case series;Abolmaali;J Clin Neurosci,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral Facial Paralysis in an Atypical Clinical Onset of COVID-Associated Guillain-Barre Syndrome;Cureus;2024-06-30

2. Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?;Handbook of Clinical Neurology;2024

3. Manifestation of Guillain-Barre Syndrome After Infection with SARS-CoV-2 versus Other Prior Infections;2023-12-04

4. What Is the Impact of the Novel Coronavirus and the Vaccination on Guillain–Barre Syndrome?;Molecular Neurobiology;2023-09-20

5. Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review;Frontiers in Neuroscience;2023-04-25